Home/ Stocks/ HUMA

Humacyte, Inc. Common Stock

HUMA XNAS

$1.06 -0.04 (-3.58%) ▼ 15-min delayed

Open

$1.07

High

$1.09

Low

$1.01

Volume

5.59M

Market Cap

$235.34M

About Humacyte, Inc. Common Stock

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 184 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$2.04M	$-40,833,000	$-0.26
FY 2025	$2.04M	$-40,833,000	$-0.26
Q3 2025	$753.0K	$-17,510,000	$-0.11
Q2 2025	$301.0K	$-37,658,000	$-0.24

Related Market News

No specific coverage for HUMA yet. Check out our latest market news or earnings calendar.

Get HUMA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Humacyte, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.